Viewing Study NCT01596751


Ignite Creation Date: 2025-12-24 @ 11:56 PM
Ignite Modification Date: 2026-05-27 @ 9:34 PM
Study NCT ID: NCT01596751
Status: COMPLETED
Last Update Posted: 2020-07-17
First Post: 2012-05-07
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Phase Ib/II Study of PLX 3397 and Eribulin in Patients With Metastatic Breast Cancer
Sponsor: Hope Rugo, MD
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastatic Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None metastatic View
None breast View
None cancer View
None triple View
None negative View
None PLX View
None Eribulin View